Cardiovascular Grand Rounds: Dr. Adam Caldwell, “Genetics of Dilated Cardiomyopathy”
Speaker: Adam Caldwell, MD, Chief Fellow, UNC CardiologyTopic: Genetics of Dilated Cardiomyopathy
Events
10 events found.
Events
-
-
-
MHI Seminar Series: Kari North, PhD, Genetic Diversity Turns a New PAGE in Our Understanding of Complex Traits
Speaker: Kari North, PhDTopic: Genetic Diversity Turns a New PAGE in Our Understanding of Complex Traits Presentation Preview: Genome-wide association studies (GWAS) have laid the foundation for many downstream investigations, including the biology of complex traits, drug development, and clinical guidelines. However, the dominance of European-ancestry populations in GWAS creates a biased view of human … Read more
-
Medicine Grand Rounds, Jonathan Juliano and Steve Meshnick, “Evolving Concepts in Malaria Control and Treatment”
In 2015, there were 212 million malaria cases worldwide, with the majority of deaths occurring in sub-Saharan Africa. In addition to the human burden of malaria, the economic burden is vast. It is thought to cost African countries more than $12 billion every year in direct losses. For more than a decade, Drs. Juliano and … Read more
-
McAllister Heart Institute Seminar Series: Timothy Haystead, PhD, Defining Novel Therapeutic Targets for Cardiovascular Disease through Chemical Biology
Speaker: Timothy Haystead, PhD, Professor of Pharmacology and Cancer Biology, Duke University School of MedicineTopic: Defining Novel Therapeutic Targets for Cardiovascular Disease through Chemical Biology
-
Medicine Grand Rounds, William Fischer and David Wohl, “Ebola and Lassa Fever: New Concepts of Epidemiology and Therapy”
David Wohl, MDWilliam Fischer, MDSevere acute viral infections are one of the world's most common causes of hospitalization and mortality with worse outcomes disproportionately affecting resource-constrained countries. In the past 15 years we have witnessed the emergence or re-emergence of several viral pathogens that threaten global public health including SARS, pandemic H1N1 Influenza, MERS-CoV, and … Read more
-
Cardiovascular Grand Rounds: Dr. Szymon Wiernek, Coronary Artery Disease in Patients with End-stage Renal Disease
Speaker: Szymon Wiernek, MD, PhD, Fellow, UNC CardiologyTopic: Coronary Artery Disease in Patients with End-stage Renal Disease
-
McAllister Heart Institute Seminar Series: Ming C. Gong, MD, PhD, Disrupted Circadian Rhythms of Blood Pressure and Vascular Function in Diabetes
Speaker: Ming Cui Gong, PhD, MD Professor of Physiology and Cardiovascular Research Center, University of Kentucky College of MedicineTopic: Disrupted Circadian Rhythms of Blood Pressure and Vascular Function in Diabetes
-
Medicine Grand Rounds, David Rubinow “Reproductive Mood Disorders: This Is Your Brain on Steroids”
Both basic and clinical studies suggest that reproductive steroids regulate virtually every element of neural signaling and do so in a highly context dependent fashion, with contexts including cell type, metabolic profiles, developmental stage/age, sex, environment, past experience, and genotype. Reproductive endocrine-related mood disorders in women (premenstrual dysphoric disorder, perinatal depression, and perimenopausal depression) offer … Read more
-
-
Medicine Grand Rounds, Maya Styner “Is Fat in the Marrow Harmful to Bone Health?”
Dr. Styner conducts translational experiments applying running exercise in obese as well as calorie-restricted mice to understand the relationship between bone fat and bone quantity. Her background in Endocrinology and skeletal biology, combined with an interest in exercise physiology, makes this an exciting venue for research into diet and exercise, which may be the most … Read more
-
Cardiovascular Grand Rounds: Craig R. Lee, PharmD, PhD, Clinical outcomes and sustainability of using CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention
Speaker: Craig R. Lee, Pharm.D., Ph.D., FCCP, FAHA. Associate Professor of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of PharmacyTopic: Clinical outcomes and sustainability of using CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention